Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Quoin Pharmaceuticals Ltd DRC
QNRXCurrent price
0.69 USD
-0.047 USD (-6.38%)
Last closed
0.73 USD
Company
quoinpharma.com
ISIN
US74907L1026
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
3 829 707 USD
Yield for 12 month
-84.34 %
1Y
3Y
5Y
10Y
15Y
QNRX
Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). The company is also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat NS; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. The company was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. operates as a subsidiary of Skinvisible, Inc. Address: 42127 Pleasant Forest Court, Ashburn, VA, United States, 20148-7349
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
4.67 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-103 438 USD
Last Year
-103 635 USD
Current Quarter
-24 908 USD
Last Quarter
-25 277 USD
Key Figures QNRX
1 year
3 years
5 years
10 years
EBITDA
-8 836 608 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-36.32 %
PEG Ratio
–
Return On Equity TTM
-100.03 %
Wall Street Target Price
4.67 USD
Revenue TTM
–
Book Value
1.88 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-5.05 USD
Diluted Eps TTM
-5.05 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics QNRX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History QNRX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:12
Payout Ratio
–
Last Split Date
18.07.2023
Dividend Date
23.10.2019
Stock Valuation QNRX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-0.4219
Price Book MRQ
0.5121
Financials QNRX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators QNRX
For 52 weeks
0.48 USD
5.75 USD
50 Day MA
0.64 USD
Shares Short Prior Month
15 195
200 Day MA
1.09 USD
Short Ratio
0.2
Shares Short
19 172
Short Percent
0.48 %
BeatStart